Multi-omics–based machine learning model predicts response and guides treatment in Crohn disease: a case study in nutritional therapy
Inflammatory Bowel Diseases · 01.08.2026 · 32 (8) · 1513-1523
DOI: 10.1093/ibd/izag060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 04.05.2026. Verfasst von Asaf Azulay und 17 weiteren Autor:innen. Beteiligte Einrichtung: Juliet Keidan Institute of Pediatric Gastroenterology Hepatology and Nutrition, The Eisenberg R&D Authority, Shaare Zedek Medical Center, The Hebrew …. Hauptthemen laut MEDLINE: Crohn Disease, Machine Learning, Enteral Nutrition. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Leona M. and Harry B. Helmsley Charitable Trust, academic grant from the International Organization of Inflammatory Bowel Diseases.
Abstract (Originalsprache)
Background
Biomarkers are needed to predict treatment response and guide therapeutic decisions in Crohn disease (CD). We aimed to develop and validate a multi-omics machine learning (ML) model to predict response to nutritional therapy in pediatric CD.
Methods
Treatment-naive children with newly diagnosed CD who were initiating exclusive enteral nutrition (EEN) were prospectively enrolled in this study. Metabolomics and lipidomics were measured in the serum and stool, as well as the fecal microbiome. Following feature selection via minimum redundancy maximum relevance, random-forest models were constructed for single- and multi-omics and performances were evaluated. The models were externally validated in an independent prospective cohort of treatment-naive children and young adults with CD treated with EEN.
Results
The discovery cohort consisted of 50 children (mean ± SD age 14.3 ± 2.7 years), of whom 34 (68%) responded to EEN. Combining complementary signals from host metabolism, gut microbiota, and lipid profiles from serum and stool in a multi-omics ML model yielded a model for predicting treatment response (training accuracy 94%; 95% CI, 82%-100%). Key predictive features included serum metabolites (2-hydroxyglutaric acid, Cer[d18:0/22:0], and HexCer[d18:1/d26:1]), fecal metabolites (3-methyladipic acid, DG[16:0 20:0], PC aa C42:2), and microbial taxa (family Bifidobacteriaceae and genus CAG-56). The validation cohort consisted of 21 patients of whom 12 (57%) responded to EEN. The multi-omics model performance achieved an area under the receiver operating characteristic curve (AUROC) of 0.81 (95% CI, 0.6-1.0). Clinical and endoscopic features did not improve the predictive ability of the model.
Conclusion
As a proof-of-concept, we showed that integrated multi-omics ML models can predict EEN response in pediatric CD patients, supporting their potential use in precision nutrition and personalized care strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Juliet Keidan Institute of Pediatric Gastroenterology Hepatology and Nutrition, The Eisenberg R&D Authority, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem Israel.
- School of Computer Science, Tel Aviv University, Tel Aviv, Israel.
- Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Santa Fe Institute, Santa Fe, NM, United States.
- Pediatric Gastroenterology Unit, Assaf Harofeh Medical Center, Zerifin, Israel.
- Pediatric Gastroenterology Institute, "Dana-Dwek" Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
ORCID-Profile: Asaf Azulay, Elhanan Borenstein, Oren Ledder, Dan Turner
Förderung
- Leona M. and Harry B. Helmsley Charitable Trust
- academic grant from the International Organization of Inflammatory Bowel Diseases
Zitieren
APA
Azulay, A., Gotesdyner, L., Aharoni-Frutkoff, Y., Focht, G., Talmor, Y., Borenstein, E., Plotkin, L., Orlanski-Meyer, E., Lev-Tzion, R., Ledder, O., Yogev, D., Assa, A., Broide, E., Yerushalmy-Feler, A., Kierkuś, J., Schwerd, T., Wine, E., & Turner, D. (2026). Multi-omics–based machine learning model predicts response and guides treatment in Crohn disease: a case study in nutritional therapy. Inflammatory Bowel Diseases, 32(8), 1513-1523. https://doi.org/10.1093/ibd/izag060
Vancouver
Azulay A, Gotesdyner L, Aharoni-Frutkoff Y, Focht G, Talmor Y, Borenstein E, et al. Multi-omics–based machine learning model predicts response and guides treatment in Crohn disease: a case study in nutritional therapy. Inflammatory Bowel Diseases. 2026;32(8):1513-1523. doi:10.1093/ibd/izag060
BibTeX
@article{Azulay2026,
author = {Azulay, Asaf and Gotesdyner, Leora and Aharoni-Frutkoff, Yonat and Focht, Gili and Talmor, Yael and Borenstein, Elhanan and Plotkin, Luba and Orlanski-Meyer, Esther and Lev-Tzion, Raffi and Ledder, Oren and Yogev, Dotan and Assa, Amit and Broide, Efrat and Yerushalmy-Feler, Anat and Kierkuś, Jarosław and Schwerd, Tobias and Wine, Eytan and Turner, Dan},
title = {Multi-omics–based machine learning model predicts response and guides treatment in Crohn disease: a case study in nutritional therapy},
journal = {Inflammatory Bowel Diseases},
year = {2026},
volume = {32},
number = {8},
pages = {1513--1523},
doi = {10.1093/ibd/izag060}
}
EUVIMED